Antiphospholipid antibodies in arterial thrombosis

Annals of Medicine

Volumn 32, Issue SUPPL. 1, 2000, Pages 27-31

  Koike, T ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

2 glycoprotein I; Antiphospholipid antibodies; Antiphospholipid syndrome; Atherosclerosis; Oxidized low density lipoprotein; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; PHOSPHOLIPID ANTIBODY;

AMINO ACID SEQUENCE; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; CELL ADHESION; CONFERENCE PAPER; GLYCOSYLATION; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ARTERIOSCLEROSIS; BETA 2-GLYCOPROTEIN I; CORONARY DISEASE; EPITOPES; GLYCOPROTEINS; HUMANS; LIPOPROTEINS, LDL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE GLYCOPROTEINS; THROMBOSIS;

EID: 0034515164     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. The anticardiolipin syndrome
2. Beta2-glycoprotein I and antiphospholipid syndrome
3. A primary antiphospholipid syndrome?
4. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: Beta2-glycoprotein I (apolipoprotein H)
5. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
6. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease
7. Anticardiolipin antibodies recognize beta2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface
8. Antigenic specificity of the 'anticardiolipin' antibodies
9. Human beta2-glycoprotein I as an anticardiolipin cofactor determined using deleted mutants expressed by a baculovirus system
10. Anticardiolipin antibodies in NZW x BXSB mice: A model of antiphospholipid syndrome
11. Beta2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome
12. Beta2-glycoprotein I (apolipoprotein H) interactions with phospholipid vesicles
13. The binding of beta2-glycoprotein I to human serum lipoproteins: Distribution among density fractions
14. Prothrombinase activity of human platelets is inhibited by beta2-glycoprotein I
15. Beta2-glycoprotein I: A plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway
16. Anti-beta2-glycoprotein I (beta2-GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2-GPI binding to phospholipid
17. Relationship between anti-phospholipid and anti-endothelial cell antibodies III: Beta2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules
18. Role of beta2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro
19. Beta2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface
20. Beta2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies
21. Crossreaction between antibodies to oxidized low-density lipoprotein and to cardiolipin in systemic lupus erythematosus
22. Involvement of beta2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages
23. Oxidized low-density lipoprotein (Ox-LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS)
24. Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I
25. Immunolocalization of beta2-glycoprotein I (apolipoprotein I) to human atherosclerotic plaques: Potential implications for lesion progression
26. Cardiovascular manifestations of systemic lupus erythematosus
27. Ischemic heart disease in systemic lupus erythematosus in the young patient: Report of six cases